Presentation, management and outcome of axillary recurrence from breast cancer
- 1 October 2000
- journal article
- Published by Elsevier BV in The American Journal of Surgery
- Vol. 180 (4), 252-256
- https://doi.org/10.1016/s0002-9610(00)00456-6
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- The Sentinel Node in Breast Cancer — A Multicenter Validation StudyThe New England Journal of Medicine, 1998
- Histopathologic Validation of the Sentinel Lymph Node Hypothesis for Breast CarcinomaAnnals of Surgery, 1997
- Does Information From Axillary Dissection Change Treatment in Clinically Node-Negative Patients With Breast Cancer?Annals of Surgery, 1997
- Axillary lymph node dissection for t1a breast carcinoma. Is it indicated?Cancer, 1994
- Impact of axillary lymph node dissection on the therapy of breast cancer patients.Journal of Clinical Oncology, 1993
- Assessment of morbidity from complete axillary dissectionBritish Journal of Cancer, 1992
- Arm function after axillary dissection for breast cancer: A pilot study to provide parameter estimatesJournal of Surgical Oncology, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 womenThe Lancet, 1992
- Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma.Journal of Clinical Oncology, 1991
- Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989